Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING Study.
Jeremy PettusRonan RousselFang Liz ZhouZsolt BosnyakJukka WesterbackaRachele BerriaJavier JimenezBjörn EliassonIrene HramiakTimothy BaileyStephen H MandyPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2019)
Sanofi, Paris, France.